05:01 PM EST, 03/03/2025 (MT Newswires) -- Enfusion ( ENFN ) reported Q4 adjusted earnings late Monday of $0.03 per diluted share, down from $0.04 a year earlier.
Analysts surveyed by FactSet expected $0.06.
Revenue for the quarter ended Dec. 31 was $52.9 million, up from $46.5 million a year earlier.
Analysts polled by FactSet expected $54.3 million.